Dermacyd Femina Pocket BR (Lactic Acid)- Acceptability.

Phase 3

Completed

• Conditions: Hygiene
• Interventions: Drug: Dermacyd Femina Pocket BR (Lactic Acid)

• Registration Number: NCT00794612
• Lead Sponsor: Sanofi

Brief Summary

The purpose of this study is to prove the safety of the gynaecological formulation in normal conditions of use.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-11
• Primary Completion: 2008-11
• Study First Submitted: 2008-11-17
• Study First Submitted QC: 2008-11-19
• Study First Posted: 2008-11-20
• Status Verified: 2008-12
• Last Update Submitted: 2008-12-18
• Last Update Posted: 2008-12-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Female
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
1	Dermacyd Femina Pocket BR (Lactic Acid)	Dermacyd Femina Pocket BR (Lactic Acid)

Primary Outcome Measures

Name	Time	Method
Absence of irritation	From the start to the end of the study
Good acceptability	From the start to the end of the study

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office; 🇧🇷 Sao Paulo, Brazil